Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC “Disappointed” By Abundance Of Red Flag Weight-Loss Ads

This article was originally published in The Tan Sheet

Executive Summary

FTC is considering what steps it will take in response to a "disappointing" run of advertisements containing "red flag" weight-loss claims by the print media in recent months, according to Richard Cleland, assistant director of the commission's Division of Advertising Practices

You may also be interested in...



Iovate claims challenged

The Electronic Retailing Self-Regulation Program forum recommends Iovate Health Sciences modify or discontinue some claims for its Cylaris and Rapid Slim SX weight-loss products in two May 16 decisions. WellNx Life Sciences, a competing supplement company, challenged Iovate's claims for both Cissus quadrangularis-containing products in the self-regulatory forum. ERSP determines Iovate provides reasonable basis for claims such as "contains proven, clinical-strength ingredients" but available public research does not support Iovate's "World's Strongest Weight-Loss Formula" or "World's Fastest Weight-Loss Solution" claims. ERSP cautions Iovate's "lose up to 32 lbs in 8 weeks" claim for Cylaris arguably qualifies as an inherently misleading statement under FTC's Red Flag Guide on weight-loss claims (1"The Tan Sheet" April 17, 2006, p. 10)...

Iovate claims challenged

The Electronic Retailing Self-Regulation Program forum recommends Iovate Health Sciences modify or discontinue some claims for its Cylaris and Rapid Slim SX weight-loss products in two May 16 decisions. WellNx Life Sciences, a competing supplement company, challenged Iovate's claims for both Cissus quadrangularis-containing products in the self-regulatory forum. ERSP determines Iovate provides reasonable basis for claims such as "contains proven, clinical-strength ingredients" but available public research does not support Iovate's "World's Strongest Weight-Loss Formula" or "World's Fastest Weight-Loss Solution" claims. ERSP cautions Iovate's "lose up to 32 lbs in 8 weeks" claim for Cylaris arguably qualifies as an inherently misleading statement under FTC's Red Flag Guide on weight-loss claims (1"The Tan Sheet" April 17, 2006, p. 10)...

Iovate claims challenged

The Electronic Retailing Self-Regulation Program forum recommends Iovate Health Sciences modify or discontinue some claims for its Cylaris and Rapid Slim SX weight-loss products in two May 16 decisions. WellNx Life Sciences, a competing supplement company, challenged Iovate's claims for both Cissus quadrangularis-containing products in the self-regulatory forum. ERSP determines Iovate provides reasonable basis for claims such as "contains proven, clinical-strength ingredients" but available public research does not support Iovate's "World's Strongest Weight-Loss Formula" or "World's Fastest Weight-Loss Solution" claims. ERSP cautions Iovate's "lose up to 32 lbs in 8 weeks" claim for Cylaris arguably qualifies as an inherently misleading statement under FTC's Red Flag Guide on weight-loss claims (1"The Tan Sheet" April 17, 2006, p. 10)...

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099285

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel